Literature DB >> 21095409

Urinary tract infections in women.

Elodi J Dielubanza1, Anthony J Schaeffer.   

Abstract

Urinary tract infection (UTI) is the most common extraintestinal infectious disease entity in women worldwide, and perhaps one of the most formidable challenges in clinical practice given its high prevalence, frequent recurrence, and myriad associated morbidities in the setting of rapidly evolving antimicrobial resistance. Achieving timely symptom relief and infection control and preventing morbidity, growth of resistant organisms, and recurrent infection are often difficult. This article reviews epidemiology and pathogenesis of urinary tract infection in women; characterizes common patterns of infection, clinical red flags, and appropriate laboratory testing and imaging; explores emerging patterns of antimicrobial resistance; and reviews the updated guidelines for the treatment of uncomplicated UTI in women.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21095409     DOI: 10.1016/j.mcna.2010.08.023

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  70 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

2.  Guidelines for the diagnosis and management of recurrent urinary tract infection in women.

Authors:  Shawn Dason; Jeyapandy T Dason; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

3.  Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial.

Authors:  Ann E Stapleton; James Dziura; Thomas M Hooton; Marsha E Cox; Yuliya Yarova-Yarovaya; Shu Chen; Kalpana Gupta
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 4.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

5.  Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.

Authors:  Patrick D Vigil; Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

Review 6.  Immunity to uropathogens: the emerging roles of inflammasomes.

Authors:  Claire Hamilton; Lionel Tan; Thomas Miethke; Paras K Anand
Journal:  Nat Rev Urol       Date:  2017-03-07       Impact factor: 14.432

7.  Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders.

Authors:  Andreja Erman; Veronika Križan Hergouth; Matthew G Blango; Mojca Kerec Kos; Matthew A Mulvey; Peter Veranic
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

Review 8.  Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.

Authors:  Laurel K Mydock-McGrane; Thomas J Hannan; James W Janetka
Journal:  Expert Opin Drug Discov       Date:  2017-06-02       Impact factor: 6.098

9.  Sex-differentiated changes in C-reactive protein from ages 9 to 21: the contributions of BMI and physical/sexual maturation.

Authors:  Lilly Shanahan; William E Copeland; Carol M Worthman; Alaattin Erkanli; Adrian Angold; E Jane Costello
Journal:  Psychoneuroendocrinology       Date:  2013-05-25       Impact factor: 4.905

10.  Prevention of recurrent urinary tract infections by intravesical administration of heparin: a pilot study.

Authors:  Tova Ablove; Manish Patankar; Songwon Seo
Journal:  Ther Adv Urol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.